Inland Peptides

Research guide

Peptide Advocacy Organizations and Research Associations: Who Can Join and How to Get Involved

October 27, 2026

Peptide advocacy organizations and research societies offer ways to support policy work, learn from scientists, and connect with industry peers. Membership ranges from $5 a year for eligible students to thousands for business programs. But some organizations do not offer public membership.

This guide compares nine organizations, including their work, eligibility rules, membership costs, benefits, and ways to get involved.

Comparison of peptide organizations

Organization Main focus Who can join Annual cost
American Academy of Peptide Medicine Policy advocacy, clinical standards Not publicly specified Not published
Alliance for Pharmacy Compounding Trade association, advocacy Pharmacies, pharmacists, prescribers, technicians, students, supporters $5 to $475 for individual categories; facility dues calculated
American Peptide Society Peptide chemistry and biology research Scientists, postdocs, students; publication or member sponsorship required Not published
European Peptide Society Peptide science research and training Researchers meeting a publication or patent test Free
International Peptide Society Clinician education in peptide therapy Clinicians $499
American Peptide Association Commercial support for peptide businesses No published eligibility criteria $2,388 or $7,188 (advertised monthly, billed annually)
Peptide Therapeutics Foundation Peptide drug development, annual symposium No public individual program Corporate sponsorship only
American Association of Pharmaceutical Scientists Pharmaceutical sciences, broad scope Scientists, postdocs, students, retirees $0 to $255, by category
Partnership for Safe Medicines Drug safety advocacy, opposes compounding these peptides Organizations and individuals Dues not published

Membership fees and eligibility were checked against publicly available information in October 2026. “Not published” means no public price could be verified.

American Academy of Peptide Medicine

AAPM describes itself as “the official nonprofit academic society for peptide medicine.” Its site says it was established in 2025.

AAPM advocates moving certain peptides into Category 1 of the FDA’s interim policy for compounding with bulk drug substances. It says that would allow licensed pharmacies to prepare eligible peptides for patients under applicable compounding standards rather than leave demand to unregulated sources.

Organization type: Advocacy group and professional society, self-described as a nonprofit academic society.

Primary focus: Federal policy advocacy on peptide compounding, plus clinical and quality standards for practitioners.

Who can join: Not publicly specified. The site invites visitors to “join the professional society” and offers account registration, but it publishes no membership categories or eligibility criteria.

Membership cost: Not published. The sign-up page creates an account and refers to “membership benefits” but does not list them or state a price.

Membership benefits: Not itemized publicly. Freely available resources include PepCheck, an app that grades a peptide source against accredited facilities. They also include a legislative tracker and a tool for writing to elected representatives.

What AAPM has actually done

The federal regulatory meeting record lists AAPM as the requestor of a meeting on the FDA’s “Interim Access Policy for Compounding Using Certain Peptides,” scheduled for 3:00 pm on October 21, 2026. The requestor is named as Lee Rosebush, the Academy’s chairman. Semafor reported on October 19 that the Academy was “slated to meet with the Office of Management and Budget” that week.

The record establishes two things: the organization requested the meeting, and the meeting was scheduled. It is a meeting with the Office of Information and Regulatory Affairs rather than the President, the Secretary of Health and Human Services, or FDA leadership. The entry lists no attendees, nor does it establish that the meeting took place. Meanwhile, the rule itself was received for review on October 14, 2026. It is still pending as of the date of this publication.

Separately, AAPM is listed by outside counsel tracking the docket among the organizations that filed comments supporting the inclusion of peptides before the July 2026 advisory committee meeting. It also held its PepMed congress in Washington on September 17 and 18, 2026, which it describes as drawing roughly 300 physicians, pharmacists, manufacturers, researchers and legislators.

AAPM publishes its advisory board in three parts. The government advisory board includes Phil Bryant, a former governor of Mississippi, and Ricardo Rossello, a former governor of Puerto Rico. The medical advisory board lists practicing physicians and nurse practitioners, while the industry advisory board lists executives of compounding pharmacies.

How to join: Create an account at pepmed.org/join. Dues and eligibility are not stated, so ask directly what membership includes before paying anything.

Official website: pepmed.org

Alliance for Pharmacy Compounding

APC is a trade association for pharmacy compounding. It publishes annual dues for five individual membership categories, while facility membership is priced separately. It has also submitted a specific peptide-compounding proposal to the FDA.

Organization type: Trade association. Its about page describes the Pharmacy Compounding Foundation as its nonprofit educational arm.

Primary focus: Federal and state advocacy for pharmacy compounding and patient access to compounded medicines.

Who can join: Compounding pharmacies and facilities, pharmacists, prescribers, pharmacy technicians and pharmacy students. A Supporter category covers people whose employer is not a member facility. So for most individuals outside pharmacy, that category is the route in.

Membership cost: All individual dues are annual: Pharmacist $475, Prescriber $250, Supporter $250, Technician $100, Pharmacy Student $5. Pharmacy and facility dues are calculated through a form rather than listed.

Membership benefits: Federal and state legislative and regulatory monitoring, grassroots calls to action, a Legal Action Fund and a political action committee, a weekly newsletter, state-by-state resources, and events such as EduCon, the Owner Summit, Compounders on Capitol Hill and a Legal Issues in Compounding Symposium.

What APC has actually done

APC asked the FDA for interim enforcement discretion covering patient-specific compounding of selected peptides, on five conditions: verified sourcing of ingredients meeting cGMP standards, preparation to USP standards, expanded patient disclosures, reporting of serious adverse events, and limited utilization reporting.

APC presented the proposal in FDA listening sessions. Speakers included board chair Philip Smyth, advocacy chief Tenille Davis, CEO Scott Brunner, and a researcher from Emory University’s Rollins School of Public Health. Brunner said afterward that the FDA appeared to be “seriously considering an interim framework much like what we’ve proposed.”

APC also filed comments supporting inclusion ahead of the July advisory meeting, and Brunner has been the trade association voice quoted in coverage of the vote, pointing out that the FDA still has to adopt the committee’s recommendations before any compounding becomes lawful.

White House review meetings on the rule

Separately from the listening sessions, APC requested a meeting with the White House Office of Information and Regulatory Affairs on the proposed interim policy. The federal record lists the requestor as Alliance for Pharmacy Compounding, the requestor’s name as Scott Brunner, and the meeting as scheduled for 2:00 pm on October 27, 2026. A listening session with agency staff and a regulatory review meeting at the Office of Information and Regulatory Affairs are two different things. In addition, the record does not establish that the October 27 meeting has taken place.

As of October 23, 2026, the register lists six scheduled meetings on this rule. Four were requested by organizations in their own name: the Alliance for Pharmacy Compounding, the American Academy of Peptide Medicine, the Center for Science in the Public Interest and Hims and Hers Health. The other two were filed by government relations firms on behalf of clients, so the six records do not represent six advocacy organizations.

How to join: Pick a category on the membership page and apply through the member portal.

Official website: a4pc.org

American Peptide Society

Founded in 1990, the American Peptide Society is the established scientific body for peptide chemistry and biology in North America. Its about page puts membership at roughly 2,100 people across North America and more than fifty-six other countries.

Organization type: Nonprofit scientific and educational organization.

Primary focus: Advancing knowledge of peptide chemistry and biology through its symposium, awards and publications.

Who can join: Four categories: Professional, Student, Postdoc and Retired Professional. New applicants must either have published in peptide science or be sponsored by a current member, so there is no open public membership.

Membership cost: Not published. The membership page lists categories and benefits but no dues figures.

Membership benefits: Reduced registration for the American Peptide Symposium, eligibility for its awards and travel grants, and professional networking. The society identifies Biopolymers as its official journal as of 2026. It also says its Wiley partnership provides complimentary electronic access to Biopolymers for members.

Research activities: A biennial international symposium, and awards including the Merrifield Award, the Vincent du Vigneaud Award, the Murray Goodman Award, the Rao Makineni Lectureship and an early career lectureship.

How to join: Apply through the membership page, which routes to an application and a status check. Expect to supply either a publication record or a sponsoring member.

Official website: americanpeptidesociety.org

European Peptide Society

The European Peptide Society was founded in 1989, then constituted as a scientific society in March 2012, based in Prato, Italy. Its statutes also describe it as “a non-profit, non-political organization.” It reports roughly 1,600 members across about thirty countries. Membership is free to eligible applicants.

Organization type: Non-profit scientific society.

Primary focus: Promoting peptide science research and training across Europe and beyond, and coordinating with equivalent societies worldwide.

Who can join: Full membership requires one published peer-reviewed paper, two proceedings publications, or one accepted patent. Temporary membership requires written support from an existing member and lapses after three years unless renewed. The society states that membership is open to academic and individual industrial applicants who can show a commitment to peptide research.

Membership cost: Free. The society’s own wording is that membership “is free of charge at present.”

Membership benefits: The biennial European Peptide Symposium, which draws roughly 800 to 1,000 participants, travel grants, funding for national meetings and workshops, a newsletter, and eligibility for its awards.

Research activities: The Josef Rudinger Memorial Lecture Award, the Leonidas Zervas Award and the Miklos Bodanszky Award, plus mobility fellowships for PhD students visiting laboratories elsewhere in Europe. The Journal of Peptide Science is its official journal, though published commercially and not financially supported by the society.

How to join: Register through the society profile page with evidence of the publication or patent requirement.

Official website: eurpepsoc.com

International Peptide Society

The International Peptide Society is a paid, clinician-oriented peptide education membership offered through the American Academy of Anti-Aging Medicine. Its membership page is hosted on the A4M site. Membership is also bought through the A4M cart, and the page footer lists A4M and Informa Connect. The Society does not publish a separate logo, so the A4M mark appears above in its place.

It describes itself as “the premier educational resource for safe and advanced peptide therapy in the nation.” James LaValle chairs both the Society and A4M’s peptide certification program.

Organization type: Paid clinician education membership, offered through A4M.

Primary focus: Teaching clinicians how peptides are used in practice, through monographs, webinars and course discounts.

Who can join: Framed for “any clinician interested in” integrating peptide therapeutics. But no specific credential or license requirement is stated on the page.

Membership cost: $499 for one year, listed on the A4M membership page and renewed annually.

Membership benefits: A peptide monograph library covering mechanisms, indications, dosing and safety; discounts on Society courses and on Informa Connect medical education; a webinar series; and access to peer-reviewed abstracts and articles. A members-only forum is listed as coming soon.

Educational activities: Peptide certification modules run through A4M. These are continuing education courses rather than a license or a government certification.

How to join: Buy membership through the IPS membership page.

Official website: a4m.com/ips-membership.html

American Peptide Association

The American Peptide Association sells two annual membership tiers to peptide businesses through an online store. Yet it does not publish a tax or corporate status.

Organization type: Commercial membership service for industry participants.

Primary focus: Compliance, vendor access and business support for companies operating in the peptide market.

Who can join: No eligibility criteria or vetting process is published. Still, the tiers are aimed at people running peptide businesses.

Membership cost: Two tiers, both quoted monthly but billed annually: Industry Membership at $199 a month, billed annually at $2,388, and Industry Insider Membership at $599 a month, billed annually at $7,188. In other words, the monthly figure is a rate, not a monthly payment option.

Membership benefits: Consultations with legal, marketing and accounting professionals, a webinar library, group purchasing with vetted vendors, a state-by-state regulatory link library, a forms library and event discounts. The higher tier adds a monthly members-only call with experts and regulators, discussions led by its regulations and compliance committee, and an expanded forms library.

Advocacy or research activities: No specific federal advocacy activity was independently verified for this article. Instead, its published activity is educational and commercial: committees, webinars and vendor arrangements.

How to join: Subscribe on the membership page. Eligibility rules are not published, so confirm what the consultations and group purchasing cover before committing to a year.

Official website: americanpeptide.co

Peptide Therapeutics Foundation

The Peptide Therapeutics Foundation is a 501(c)(3) not-for-profit established in 2008 to promote the research and development of peptide therapeutics. It offers no individual membership program; people can instead attend its symposium or inquire about corporate sponsorship.

Organization type: 501(c)(3) charitable foundation.

Primary focus: Bringing together academia, biopharmaceutical companies, contract manufacturers and research organizations, and investors around peptide drug development.

Who can join: No public individual membership program is listed. But symposium attendance and corporate sponsorship provide other ways to participate.

Membership cost: Not applicable to individuals. The foundation does, however, list several corporate sponsorship tiers.

Research activities: The Annual Peptide Therapeutics Symposium in San Diego. The twenty-first was held at the Scripps Seaside Forum on October 20 and 21, 2026. Standing corporate sponsors listed by the Foundation include Ferring Pharmaceuticals, Neurocrine Biosciences, Novo Nordisk, PolyPeptide and Zealand Pharma.

How to get involved: Register for the symposium or approach the Foundation about sponsorship through its website.

Official website: peptidetherapeutics.org

American Association of Pharmaceutical Scientists

AAPS is a broad pharmaceutical sciences association. Its membership programs also serve researchers and students working on peptide formulation, drug delivery, and related fields. Its activities are not peptide-specific, so prospective members should check the current conference and education programs.

Organization type: Professional scientific association.

Primary focus: Pharmaceutical sciences across discovery, formulation, delivery and regulatory science.

Who can join: Professionals working in pharmaceutical sciences in industry, academia, government, consulting or research institutes; postdoctoral fellows; full-time students, with status verified by a dean or department chair; and retirees.

Membership cost: Annual rates from the member categories page: Regular $255, Post-Doctoral Fellow $60, Student $60, Retired $85. Two-year terms are discounted by five percent. Retired Emeritus is free for members of twenty-five years or more who are over seventy.

Membership benefits: Professional meetings, educational programs, student chapters, and networking. Benefits are general rather than specific to peptides.

How to join: Choose a category on the join page. Students also need verification from a dean or department chair.

Official website: aaps.org

Partnership for Safe Medicines

PSM opposes expanded compounding access for the seven peptides under FDA review. It describes itself as a public health group comprised of more than 45 nonprofit organizations concerned with prescription drug safety.

Organization type: Coalition of organizations focused on drug safety.

Primary focus: Protecting patients from counterfeit and unsafe medicines, including opposition to compounding substances it considers inadequately characterized.

Who can join: The members page describes PSM as a group of organizations and individuals with policies, procedures or programs to protect consumers from counterfeit and unsafe medicines. In practice the published list is organizational, running to state pharmacy associations, the National Association of Boards of Pharmacy, the American Pharmacists Association, the National Consumers League and the Pharmaceutical Researchers and Manufacturers of America.

Membership cost: Not published. The members page states that “all PSM members are expected to pay annual dues or submit a hardship waiver,” without amounts.

What PSM has actually done

On October 16, 2026, the Partnership for Safe Medicines filed a citizen petition asking the FDA to prevent the compounding of the seven peptides under consideration, whether by regulation, by addition to Category 1, or by enforcement discretion. The organization then publicly announced the petition on October 21. It also asked the agency to disregard the July advisory committee vote as a basis for rulemaking. Its executive director is Shabbir Imber Safdar.

Before that, PSM filed docket comments opposing all seven peptides, citing the absence of adequate human clinical evidence. The same docket review records the American Pharmacists Association on the same side, and the pharmaceutical industry trade group PhRMA opposing all seven as well.

PhRMA, whose member companies market FDA-approved drugs including peptide medicines, is listed among PSM’s member organizations. That affiliation provides context about the coalition’s membership, but it does not resolve the scientific or regulatory questions.

How to get involved: Individuals can join the mailing list through the about page. Because individual eligibility rules and dues are not published, anyone interested in joining should contact PSM directly to ask whether and how they can.

Official website: safemedicines.org

Which peptide advocacy organization should you join?

Match the organization to your eligibility and what you want from it.

  • If you are a member of the public who wants to support access advocacy. APC offers an annual $250 Supporter membership for people whose employers are not member facilities. It also has documented federal advocacy on peptide compounding.
  • If you are an academic researcher. The American Peptide Society in North America, the European Peptide Society in Europe, or both. The European society costs nothing, and both accept a publication record as the entry test.
  • If you are a student entering peptide science. The European Peptide Society offers free membership to eligible researchers as well as mobility fellowships for PhD students. AAPS charges $60 for student membership; the American Peptide Society also has a student category subject to its research or sponsorship requirements.
  • If you are a healthcare professional seeking peptide education. The International Peptide Society provides clinician-focused educational resources through A4M for $499 a year.
  • If you work in the peptide industry. APC may be relevant if your work involves compounding pharmacies. The American Peptide Association offers business services, but its annual fees are higher and specific federal advocacy was not verified for this guide.
  • If you want conferences and published science. Consider the Peptide Therapeutics Foundation symposium for drug development, or the American and European Peptide Symposia for peptide chemistry and biology.

Membership terms and policy activities can change. Before joining, verify current eligibility, dues, and events using the official links above.

Comparison of nine peptide advocacy and research organizations, including membership eligibility, annual dues, and documented federal advocacy as of October 2026.
Nine organizations compared by membership availability, annual cost, eligibility, and documented federal advocacy (October 2026). “No” under advocacy means no qualifying federal activity was verified for this guide.